Publication:
Treatment of choriocarcinoma metastases by surgery and polychemotherapy - Case report

dc.contributor.authorJeremić, K. (6701486495)
dc.contributor.authorGojnic, M. (9434266300)
dc.contributor.authorBošković, V. (8613866600)
dc.contributor.authorArgirović, R. (12760596400)
dc.contributor.authorMilenković, V. (13006375400)
dc.contributor.authorJeremić, J. (15022530400)
dc.date.accessioned2025-06-13T00:13:00Z
dc.date.available2025-06-13T00:13:00Z
dc.date.issued2006
dc.description.abstractChoriocarcinoma is present in one out of every 40,000 pregnancies [1]. There is a great risk for incidence of the disease in women who become pregnant after 45 years of age. The clinical picture may vary and is related to the destruction of tissue and bleeding. New chemo protocols containing etoposide, cisplatin, ifosfamide, together with a resection of the focus resistant to chemotherapy, lead in most cases to the complete recovery [1, 2].
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-33645973646&partnerID=40&md5=b9171760dc3e951d8c71f37a259f9a55
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/10929
dc.subjectChoriocarcinoma
dc.subjectPolychemotherapy
dc.titleTreatment of choriocarcinoma metastases by surgery and polychemotherapy - Case report
dspace.entity.typePublication

Files